亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

成都鈉鈳鋰生物科技有限公司  

自制標準品對照品,各類植物提取物

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:李曼
  • 電話:028-61983833
  • 郵件:cdnakeli@163.com
  • 微信:18000507060
  • QQ:1373789011
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 8-姜酚 CAS:23513-08-8
8-姜酚 CAS:23513-08-8
單價 面議對比
詢價 暫無
發貨 四川成都市付款后3天內
品牌 鈉鈳鋰
過期 長期有效
更新 2021-11-25 12:22
 
詳細信息

nkl-00221
中文名稱:8-姜酚
中文別名:8-姜辣素
英文名稱:8-Gingerol
英文別名:3-Dodecanone, 5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-, (S)-; 3-Dodecanone, 5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-, (S)-(+)- (8CI); (5S)-5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-dodecanone;  [8]-Gingerol;(5S)-[8]-Gingerol; (S)-(+)-[8]-Gingerol; (S)-[8]-Gingerol
CAS號:23513-08-8
純度: HPLC≥98%

分子式:C19H30O4
分子量:322.44
外觀:白色針晶粉
沸點: 476.4±35.0 °C | Condition
密度: 1.058±0.06 g/cm3 | Condition: Temp: 20 °C
pKa 值: 10.02±0.20 | Condition: Most Acidic Temp: 25 °C
溶解性:不溶于水和酸,微溶于堿,易溶于各種有機物質。
規格: 20mg 50mg 100mg 500mg g級等應客戶需求包裝.
提取來源:姜屬植物姜的新鮮根莖
藥理藥效:具有止嘔、強心、降壓、降血脂、抗血小板聚集、抗動脈粥樣硬化、抗腫瘤、抗氧化、抗炎、解熱鎮痛等廣泛的藥理作用。
儲存條件: 2-8°C,避光、干燥、密封

用途: 用于鑒別、含量測定、藥理實驗、活性篩選等科研、實驗室使用;不得用于注射、食用或其他

供應商:成都鈉鈳鋰生物科技有限公司

©2025 成都鈉鈳鋰生物科技有限公司 版權所有   技術支持:化工網   訪問量:21471  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |